Detalhe da pesquisa
1.
Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma.
Pract Radiat Oncol
; 13(6): e504-e514, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37295727
2.
Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
Hepatol Commun
; 7(7)2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37314737
3.
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.
J Nucl Med
; 63(6): 882-889, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34503962
4.
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis.
Transl Oncol
; 21: 101428, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35460942
5.
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy.
Transl Oncol
; 14(1): 100950, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33395747
6.
The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 111(1): 127-134, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33878421
7.
Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
Int J Radiat Oncol Biol Phys
; 109(1): 212-219, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32853708